MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development12,07621,70518,8168,640
Selling General and Administrative6,9676,5375,6163,280
Non Recurring----
Total Operating Expenses19,04328,24224,43211,920
Operating Income or Loss-19,043-28,242-24,432-11,920
Income from Continuing Operations
Total Other Income/Expenses Net145-401-4181,087
Earnings Before Interest and Taxes-19,043-28,242-24,432-11,920
Interest Expense-159-464-475-117
Income Before Tax-18,898-28,643-24,850-10,833
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-18,898-28,643-24,850-10,833
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-18,898-28,643-24,850-10,833
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-18,898-28,643-24,850-13,378